- Home
- ETY vs HROW Comparison
ETY vs HROW Comparison
Compare ETY & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETY
- HROW
- Stock Information
- Founded
- ETY 2006
- HROW 1998
- Country
- ETY United States
- HROW United States
- Employees
- ETY N/A
- HROW N/A
- Industry
- ETY Finance Companies
- HROW Biotechnology: Pharmaceutical Preparations
- Sector
- ETY Finance
- HROW Health Care
- Exchange
- ETY Nasdaq
- HROW Nasdaq
- Market Cap
- ETY 2.3B
- HROW 1.9B
- IPO Year
- ETY N/A
- HROW N/A
- Fundamental
- Price
- ETY $14.88
- HROW $43.88
- Analyst Decision
- ETY
- HROW Strong Buy
- Analyst Count
- ETY 0
- HROW 4
- Target Price
- ETY N/A
- HROW $55.00
- AVG Volume (30 Days)
- ETY 247.3K
- HROW 720.8K
- Earning Date
- ETY 01-01-0001
- HROW 11-13-2024
- Dividend Yield
- ETY 7.21%
- HROW N/A
- EPS Growth
- ETY N/A
- HROW N/A
- EPS
- ETY N/A
- HROW N/A
- Revenue
- ETY N/A
- HROW $169,138,000.00
- Revenue This Year
- ETY N/A
- HROW $58.50
- Revenue Next Year
- ETY N/A
- HROW $48.62
- P/E Ratio
- ETY N/A
- HROW N/A
- Revenue Growth
- ETY N/A
- HROW 48.15
- 52 Week Low
- ETY $10.59
- HROW $8.72
- 52 Week High
- ETY $13.46
- HROW $59.23
- Technical
- Relative Strength Index (RSI)
- ETY 57.37
- HROW 45.29
- Support Level
- ETY $14.75
- HROW $37.00
- Resistance Level
- ETY $15.01
- HROW $54.19
- Average True Range (ATR)
- ETY 0.20
- HROW 3.29
- MACD
- ETY 0.00
- HROW -0.81
- Stochastic Oscillator
- ETY 61.10
- HROW 40.02
About ETY Eaton Vance Tax-Managed Diversified Equity Income Fund of Beneficial Interest
Eaton Vance Tax-mgd Dvsf Eq Inc Fd is a diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Its portfolio of investments consists of capital markets, banks, internet and direct marketing retail, biotechnology, media, oil, gas, and consumable fuels, and other sectors.
About HROW Harrow Inc.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans.